Camptomelic dysplasia: genes and variants
Explore variant evidence for Camptomelic dysplasia across 1 analyzed protein (SOX9). Linked ClinVar records include 26 pathogenic or likely pathogenic variants, 103 variants of uncertain significance and 14 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Camptomelic dysplasia
SOX9: Transcription factor SOX-9
It controls chondrocyte differentiation, cartilage formation, and testis development and also regulates multiple organ-specific developmental programs. Haploinsufficiency causes campomelic dysplasia, often with severe skeletal abnormalities and 46,XY sex reversal.
26 ClinVar pathogenic / likely pathogenic and 117 uncertain variants in SOX9 have source records linked to Camptomelic dysplasia. Association strength is not clinical gene validity.
Where Camptomelic dysplasia variants cluster
- SOX9 HMG box (positions 105–173): 22 of 26 ClinVar pathogenic / likely pathogenic variants, 6.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Camptomelic dysplasia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SOX9 M113V | 113 | HMG box | Pathogenic / likely pathogenic (★★) |
| SOX9 P170T | 170 | HMG box | Pathogenic / likely pathogenic (★★) |
| SOX9 P170R | 170 | HMG box | Pathogenic / likely pathogenic (★★) |
| SOX9 P170S | 170 | HMG box | Pathogenic / likely pathogenic (★★) |
| SOX9 P170A | 170 | HMG box | Pathogenic / likely pathogenic (★★) |
| SOX9 P176R | 176 | Pathogenic / likely pathogenic (★★) | |
| SOX9 A158V | 158 | HMG box | Pathogenic / likely pathogenic (★★) |
| SOX9 R152P | 152 | HMG box | Pathogenic / likely pathogenic (★★) |
| SOX9 M113T | 113 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 M113L | 113 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 M113I | 113 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 Y172C | 172 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 Y172F | 172 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 P176L | 176 | Pathogenic / likely pathogenic (★) | |
| SOX9 G140D | 140 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 A158T | 158 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 K166N | 166 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 H169P | 169 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 K173E | 173 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 I73T | 73 | Dimerization (DIM) | Pathogenic / likely pathogenic (★) |
| SOX9 V105F | 105 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 M109T | 109 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 N132I | 132 | HMG box | Pathogenic / likely pathogenic (★) |
| SOX9 F154L | 154 | HMG box | Pathogenic / likely pathogenic |
| SOX9 Q164P | 164 | HMG box | Pathogenic / likely pathogenic |
| SOX9 M476T | 476 | Transactivation domain (TAC) | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Camptomelic dysplasia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SOX9 H169Q | 169 | HMG box | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; H169P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SOX9 R152G | 152 | HMG box | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; R152P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
Which prediction tools work for Camptomelic dysplasia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 99 out of 100
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 91 out of 100
- PolyPhen-2: 80 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 80 out of 100
Diseases related to Camptomelic dysplasia
- Connective tissue disease, also linked to SOX9
- Fetal anomalies with a likely genetic cause, also linked to SOX9
Frequently asked questions
Which genes have records linked to Camptomelic dysplasia?
This view contains 1 analyzed proteins: SOX9. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 26 pathogenic or likely pathogenic variants, 103 variants of uncertain significance and 14 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 169 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center